Correlation Between Madrigal Pharmaceuticals and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Effector Therapeutics, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Effector Therapeutics.
Diversification Opportunities for Madrigal Pharmaceuticals and Effector Therapeutics
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Madrigal and Effector is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Effector Therapeutics go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Effector Therapeutics
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 0.41 times more return on investment than Effector Therapeutics. However, Madrigal Pharmaceuticals is 2.45 times less risky than Effector Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Effector Therapeutics is currently generating about -0.12 per unit of risk. If you would invest 21,318 in Madrigal Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 9,959 from holding Madrigal Pharmaceuticals or generate 46.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 68.75% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Effector Therapeutics
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Madrigal Pharmaceuticals and Effector Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Effector Therapeutics
The main advantage of trading using opposite Madrigal Pharmaceuticals and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |